139 related articles for article (PubMed ID: 16361125)
21. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.
Blebea JS; Houseni M; Torigian DA; Fan C; Mavi A; Zhuge Y; Iwanaga T; Mishra S; Udupa J; Zhuang J; Gopal R; Alavi A
Semin Nucl Med; 2007 May; 37(3):185-94. PubMed ID: 17418151
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
[TBL] [Abstract][Full Text] [Related]
24. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Sloof GW
Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
[TBL] [Abstract][Full Text] [Related]
25. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
26. Intraocular lymphoma and central nervous system lymphoma involving the hypothalamus: staging and evaluation of response to therapy with F-18 FDG PET/CT.
Makis W; Novales-Diaz JA; Hickeson M
Clin Nucl Med; 2010 Dec; 35(12):956-9. PubMed ID: 21206231
[No Abstract] [Full Text] [Related]
27. Imaging of primary central nervous system lymphoma.
Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
[TBL] [Abstract][Full Text] [Related]
28. [Imaging examinations in lymphoma].
Terauchi T
Nihon Rinsho; 2014 Mar; 72(3):430-5. PubMed ID: 24724398
[TBL] [Abstract][Full Text] [Related]
29. PET/CT: More than the sum of two established imaging modalities?
Kletter K
Eur J Radiol; 2010 Mar; 73(3):449-51. PubMed ID: 20097026
[No Abstract] [Full Text] [Related]
30. Use of PET/CT to evaluate response to therapy in lymphoma.
Zanoni L; Cerci JJ; Fanti S
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583
[TBL] [Abstract][Full Text] [Related]
31. Interesting image. Situs inversus totalis in newly diagnosed lymphoma: additional value of hybrid imaging.
Trautner M; Szyszko T; Gnanasegaran G; Nunan T
Clin Nucl Med; 2010 Jan; 35(1):26-8. PubMed ID: 20026969
[No Abstract] [Full Text] [Related]
32. Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation.
Heldmann M; Behm W; Reddy MP; Bozeman C; Welman G; Abreo F; Minagar A
AJR Am J Roentgenol; 2005 Sep; 185(3):697-9. PubMed ID: 16120920
[No Abstract] [Full Text] [Related]
33. [Clinical diagnostic imaging (including FDG-PET/CT)].
Torizuka T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():198-201. PubMed ID: 23133952
[No Abstract] [Full Text] [Related]
34. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
Schwenzer NF; Pfannenberg AC
Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
[TBL] [Abstract][Full Text] [Related]
35. Comment on "Advanced carotid plaque imaging".
Tang TY; Walsh SR; Sadat U; Gillard JH
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):139; author reply 139-40. PubMed ID: 20418123
[No Abstract] [Full Text] [Related]
36. Leukemia and lymphoma.
Guillerman RP; Voss SD; Parker BR
Radiol Clin North Am; 2011 Jul; 49(4):767-97, vii. PubMed ID: 21807173
[TBL] [Abstract][Full Text] [Related]
37. Whole body MRI and PET/CT in haematological malignancies.
Lin C; Luciani A; Itti E; Haioun C; Rahmouni A
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S88-93. PubMed ID: 17921084
[TBL] [Abstract][Full Text] [Related]
38. Design and performance from an integrated PET/MRI system for small animals.
Yamamoto S; Imaizumi M; Kanai Y; Tatsumi M; Aoki M; Sugiyama E; Kawakami M; Shimosegawa E; Hatazawa J
Ann Nucl Med; 2010 Feb; 24(2):89-98. PubMed ID: 20058103
[TBL] [Abstract][Full Text] [Related]
39. [The PET, Past and Future].
Fujii H
Igaku Butsuri; 2015; 35(1):2-9. PubMed ID: 26753390
[TBL] [Abstract][Full Text] [Related]
40. Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?
Minoia C; Maggialetti N; Ferrari C; Brunese L; Rubini G; Guarini A
J BUON; 2016; 21(1):282-3. PubMed ID: 27061563
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
